Theo dõi
Prof. Dr. Christoffer Gebhardt
Prof. Dr. Christoffer Gebhardt
Email được xác minh tại uke.de
Tiêu đề
Trích dẫn bởi
Trích dẫn bởi
Năm
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
U Sahin, E Derhovanessian, M Miller, BP Kloke, P Simon, M Löwer, ...
Nature 547 (7662), 222-226, 2017
24512017
S100A8 and S100A9 in inflammation and cancer
C Gebhardt, J Németh, P Angel, J Hess
Biochemical pharmacology 72 (11), 1622-1631, 2006
8422006
Baseline biomarkers for outcome of melanoma patients treated with pembrolizumab
B Weide, A Martens, JC Hassel, C Berking, MA Postow, K Bisschop, ...
Clinical Cancer Research 22 (22), 5487-5496, 2016
6012016
Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task
TJ Brinker, A Hekler, AH Enk, J Klode, A Hauschild, C Berking, B Schilling, ...
European Journal of Cancer 113, 47-54, 2019
5322019
RAGE signaling sustains inflammation and promotes tumor development
C Gebhardt, A Riehl, M Durchdewald, J Németh, G Fürstenberger, ...
The Journal of experimental medicine 205 (2), 275-285, 2008
4712008
The role of myeloid-derived suppressor cells (MDSC) in cancer progression
V Umansky, C Blattner, C Gebhardt, J Utikal
Vaccines 4 (4), 36, 2016
4572016
Myeloid cells and related chronic inflammatory factors as novel predictive markers in melanoma treatment with ipilimumab
C Gebhardt, A Sevko, H Jiang, R Lichtenberger, M Reith, K Tarnanidis, ...
Clinical Cancer Research 21 (24), 5453-5459, 2015
3902015
Endothelial Notch1 activity facilitates metastasis
E Wieland, J Rodriguez-Vita, SS Liebler, C Mogler, I Moll, SE Herberich, ...
Cancer cell 31 (3), 355-367, 2017
3132017
A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification task
TJ Brinker, A Hekler, AH Enk, J Klode, A Hauschild, C Berking, B Schilling, ...
European Journal of Cancer 111, 148-154, 2019
3042019
Reactive neutrophil responses dependent on the receptor tyrosine kinase c-MET limit cancer immunotherapy
N Glodde, T Bald, D van den Boorn-Konijnenberg, K Nakamura, ...
Immunity 47 (4), 789-802. e9, 2017
2662017
Myeloid cell function in MRP-14 (S100A9) null mice
JAR Hobbs, R May, K Tanousis, E McNeill, M Mathies, C Gebhardt, ...
Molecular and cellular biology, 2003
2592003
Elevated chronic inflammatory factors and myeloid‐derived suppressor cells indicate poor prognosis in advanced melanoma patients
H Jiang, C Gebhardt, L Umansky, P Beckhove, TJ Schulze, J Utikal, ...
International journal of cancer 136 (10), 2352-2360, 2015
1912015
S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis
J Németh, I Stein, D Haag, A Riehl, T Longerich, E Horwitz, K Breuhahn, ...
Hepatology 50 (4), 1251-1262, 2009
1862009
Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis
C Gebhardt, U Breitenbach, JP Tuckermann, BT Dittrich, KH Richter, ...
Oncogene 21 (27), 4266-4276, 2002
1832002
CCR5+ myeloid-derived suppressor cells are enriched and activated in melanoma lesions
C Blattner, V Fleming, R Weber, B Himmelhan, P Altevogt, C Gebhardt, ...
Cancer research 78 (1), 157-167, 2018
1722018
Tumour hypoxia promotes melanoma growth and metastasis via High Mobility Group Box-1 and M2-like macrophages.
FLE Huber R, Meier B, Otsuka A, Fenini G, Satoh T, Gehrke S, Widmer D ...
Sci Rep. 6, 29914, 2016
1532016
Comparing artificial intelligence algorithms to 157 German dermatologists: the melanoma classification benchmark
TJ Brinker, A Hekler, A Hauschild, C Berking, B Schilling, AH Enk, ...
European Journal of Cancer 111, 30-37, 2019
1452019
Current and future clinical applications of ctDNA in immuno-oncology
JC Stadler, Y Belloum, B Deitert, M Sementsov, I Heidrich, C Gebhardt, ...
Cancer Research 82 (3), 349-358, 2022
1112022
CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma
V Umansky, C Blattner, C Gebhardt, J Utikal
Cancer Immunology, Immunotherapy 66, 1015-1023, 2017
932017
Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies
NB Wagner, B Weide, M Gries, M Reith, K Tarnanidis, V Schuermans, ...
Journal for ImmunoTherapy of Cancer 7, 1-10, 2019
872019
Hệ thống không thể thực hiện thao tác ngay bây giờ. Hãy thử lại sau.
Bài viết 1–20